Dr. O'Donnell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 Olive Ave
South Pasadena, CA 91030Phone+1 626-533-2353Fax+1 626-301-8973
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1977 - 1979
McGill University Faculty Medicine HospitalHematology, 1976 - 1977- McGill University Faculty Medicine HospitalInternal Medicine, 1975 - 1976
- McGill University Faculty Medicine HospitalTransitional Year, 1974 - 1975
- MCP-Hahnemann College of MedicineClass of 1974
Certifications & Licensure
CA State Medical License 1983 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 402 citationsLate mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor studySmita Bhatia, Liton Francisco, Andrea Carter, Can Lan Sun, K. Scott Baker
Blood. 2007-11-15 - 37 citationsPhase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.George Somlo, Ashkan Lashkari, William T. Bellamy, Todd M. Zimmerman, Joseph Tuscano
British Journal of Haematology. 2011-08-01 - 11 citationsAllogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase Mutations.Amandeep Salhotra, Michelle Afkhami, Dongyun Yang, Sally Mokhtari, Milhan Telatar
Clinical Lymphoma, Myeloma & Leukemia. 2019-07-01
Abstracts/Posters
- SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemi...Margaret R O'Donnell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Clinical Outcomes of MDS Patients Who Were Allogeneic Hematopoietic Stem Cell Transplant Candidates but Did Not Proceed with Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Cytokine Gene Polymorphisms Are Associated with Disease Response to Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
